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Introduction
SpA is a heterogeneous group of mostly chronic interrelated inflammatory rheumatic diseases that share a common genetic predisposition and specific clinical characteristics such as spinal inflammation, asymmetric peripheral arthritis, dactylitis and enthesitis (1) but also common extraarticular features as uveitis, psoriasis and inflammatory bowel disease.
Based on the "Assessment of SpondyloArthritis international Society" (ASAS) classification criteria, SpA can be divided into two subsets: axial SpA (axSpA) including ankylosing spondylitis (AS) and nonradiographical axial spondyloarthritis (nr-axSpA) and also peripheral SpA, including reactive arthritis (ReA), psoriatic arthritis (PsA), enteropathic arthritis and juvenile SpA (2) . The spectrum of SpA in sub-Saharan Africa remains poorly defined. In African black populations, SpA is considered to be extremely rare explained in part by the low prevalence of HLA-B27 (3) (4) (5) (6) . A completely different environment on top of a different genetic background might also be responsible for the rarity as well for a different disease presentation (7) (8) (9) (10) (11) . Few studies reported on the epidemiological, clinical, radiological features of SpA in sub-Saharan populations (3) (4) (5) (6) 12) . These studies are mostly older, biased because based on hospital cohorts and suggest differential epidemiological and clinical aspects of SpA in our region. In DR Congo, data on SpA are also scarce. A first hospital-based study reported a prevalence of 7.5% among patients attending the University Hospital of Kinshasa (UHK) for rheumatic complaints (13) . The purpose of this present study was to report in a more detailed way the spectrum of SpA and its subtypes in patients attending two rheumatology units in DR Congo.
Methods
This was a cross-sectional study conducted in the department of internal medicine of the University These two hospitals were chosen because of the existence of a Rheumatology unit. In the DR Congo there are no other rheumatology units and in total 5 rheumatologists are working in Kinshasa.
Problems in the organization of care as well as the lack of a health insurance system do not allow patients with rheumatic complaints good accessibility to health care.
All the patients visiting the outpatients clinics of these hospitals for rheumatic complaints during the study period were included. A complete clinical examination by the rheumatologist was performed.
Details of joint symptoms, back pain and stiffness, personal and family histories of arthritis, skin lesions, symptoms of acute anterior uveitis, enthesitis, dactylitis, Crohn's disease/colitis, diarrhea, urethritis, good response to non-steroidal anti-inflammatory drugs (NSAIDs) and a positive family history of SpA were recorded. The diagnosis of SpA was according to Amor and ESSG. When the criteria were not fulfilled, the rheumatologist could still make the diagnosis according to his clinical experience. According to the 2009 criteria of the ASAS, ax-SpA is categorized into nr-axSpA and AS, in F o r p e e r r e v i e w o n l y (17) . All patients were assisted by rheumatologist to complete the two questionnaires. For the patients who had a difficulty to understand the French language, the rheumatologist had proceeded to a translation in Lingala to explain different questions contained. Blood tests including erythrocyte sedimentation rate (ESR) and the serum CRP were also performed in all patients. HLA-B27 typing was not realized.
Qualitative data are described as n (%) and quantitative data as mean (SD) or median (quartile1_quartile3) as appropriate. Chi-square test was used to compare the comparison of the proportions. A student-t test was used to compare the averages. The p-value was fixed to 0.05. The study was conducted in accordance with the National Ethics Committee (ESP/CE/030/13). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Results

During
Discussion
The prevalence of SpA was 10.7% among rheumatic patients during the 6-month period of the current study and is higher than that found by Malemba and al. (7.5%) based on an extensive review of patients medical records seen by rheumatologists at the UHK. In this hospital-based study, diagnostic criteria applied by rheumatologist were used to improve clinical diagnosis while the application of the criteria of Amor and ESSG in medical records might lead to underdiagnosis.
Moreover, in our environment HLA typing is not feasible and because of the low frequency of HLA B27 also not very well performing. Because of all this, ESSG and Amor criteria would need specific validation studies in our region. We observed 105 cases of SpA and a male/female sex ratio of 1.4.
More men were affected in the total as confirmed in most of the literature reported from Africa and western countries (18) (19) (20) (21) (22) . The mean age and the age at the onset of symptom were higher than in the series reported in the western countries, but in agreement with the literature reported from the features probably because of a protective role played by the local genetic factors (7, 8) . Further genetic research could be interesting in this field. In this study we observed 10 cases of AS (1.02%).
This scarcity seems to be related to the low frequency of HLA B27 gene in this population (23) . Less male predominance has been observed among Congolese patients with SpA, AS and nr-axSpA compared to Caucasians (3). However different demographical and methodological characteristics could also contribute to the explanations of gender differences observed. The proportion of females could be underestimated because most of patients with pelvic inflammatory disease would be seen in Gynecology departments in our country where full rheumatologic evaluations and sacroiliac radiographs are not systematically performed. Patients with AS had a mean age of 48.2 years (SD 4.7)
with the age of onset typically older as reported in other sub Saharan literature and with no family history of SpA and also a relative rarity of extra-articular features, notably uveitis also in accordance with data of the literature of SpA in sub-Saharan Africa (4, 6, (20) (21) (22) .
Pertinent differences between AS and nr-axSpA (83.1% of axSpA) in this study included significantly longer disease duration and mean age at consultation for AS (p<0.05). Apart from the fact of AS developing after an initial period of disease with negative radiographical findings, this longer disease duration before consultation can also be explained by the many problems concerning organization of health care, the poverty of the Congolese population having no access to treatment, as well as by cultural specificities with difficulties in understanding the concept of chronicity of a disease (24). No significant difference was observed regarding extra articular features, parameters of disease activity and function as well as inflammatory markers including BASDAI, BASFI, ESR and CRP between these two groups. This is of course difficult to judge in a cross-sectional study of different disease entities when AS might be just the "natural evolution" of nr-axSpA (25-27). Only one case of PsA was reported in this study in a woman of 32 years old with HIV negativity. The skin lesions antedated the joint symptoms for three years, including peripheral joint involvement and sacroiliitis. This scarcity of psoriasis and PsA is in accordance to sub Saharan literature reports (3, 4, (20) (21) (22) . Further studies 
Conclusion
SpA is not rare in outpatients attending Rheumatology units in DR Congo. A population-based study would improve the understanding of this disease spectrum in central Africa. Such a study will need to take in to account the differential infectious background, problems related to the health care system and poverty of the population and differential genetics in this environment. Classification criteria validated in the western world will not necessarily perform the same in our region. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Strengths and limitations of this study
• To the best of our knowledge, this is the first more detailed study describing the spectrum of Spondyloarthritis in the Democratic Republic of Congo.
• In this hospital-based study, clinical diagnosis was followed by diagnostic criteria applied by rheumatologists strengthening the results, while the application of classification in medical records might have led to misdiagnosis.
• HLA typing and MRI were not performed due to lack of availability and economic constraints.
On the other hand applying classical ASAS criteria to an African population would perhaps not be accurate and specific validation is needed in our population.
• Relationships with sexually transmitted and other infections are lacking in our study and future work needs to draw attention to this important issue.
• A population-based study will be needed to accurately evaluate the phenotype and genotype of Spondyloarthritis in central Africa. Based on the "Assessment of SpondyloArthritis International Society" (ASAS) classification criteria, SpA can be divided into two subsets: axial SpA (axSpA) including ankylosing spondylitis (AS) and nonradiographical axial spondyloarthritis (nr-axSpA) and also peripheral SpA (pSpA), including reactive arthritis (ReA), psoriatic arthritis (PsA), enteropathic arthritis and juvenile SpA (2).
The spectrum of SpA in sub-Saharan Africa remains poorly defined. In African black populations, SpA is considered to be extremely rare explained in part by the low prevalence of HLA-B27 (3-6). A completely different environment on top of a different genetic background might also be responsible for the rarity as well for a different disease presentation (7) (8) (9) (10) (11) . Few studies reported on the epidemiological, clinical, radiological features of SpA in sub-Saharan populations (3-6, 12). These studies are mostly older, biased because based on hospital cohorts and suggest differential epidemiological and clinical aspects of SpA in our region. In DR Congo, data on SpA are also scarce. A first hospital-based study reported a prevalence of 7.5% among patients attending the University Hospital of Kinshasa (UHK) for rheumatic complaints (13) .The purpose of this present study was to report in a more detailed way the spectrum of SpA and its subtypes in patients attending two rheumatology units in DR Congo.
Methods
This was a prospective study conducted in the department of internal medicine of the UHK and the Provincial General Hospital of Kinshasa (PGHK) (Kinshasa, DR Congo, Africa) for six months, from Problems in the organization of care as well as the lack of a health insurance system do not allow patients with rheumatic complaints good accessibility to health care.
All the patients visiting the outpatients' clinics of these hospitals for rheumatic complaints during the study period were recruited consecutively. A complete clinical examination by the rheumatologist was performed. Details of joint symptoms, back pain and stiffness, personal and family histories of arthritis, skin lesions, symptoms of acute anterior uveitis, enthesitis, dactylitis, Crohn's disease/colitis, diarrhea, urethritis, good response to non-steroidal anti-inflammatory drugs (NSAIDs) were also asked to complete the BASDAI and BASFI (17) . All patients were assisted by rheumatologists to complete the two questionnaires. For the patients who had difficulty to understand the French language, the rheumatologist proceeded to a translation in Lingala to explain different questions contained. Blood tests including erythrocyte sedimentation rate (ESR) and the serum CRP were also performed in all patients. HLA-B27 typing was not realized.
Qualitative data are described as n (%) and quantitative data as mean (SD) or median (quartile1_quartile3) as appropriate. Chi-square test was used to compare the comparison of the proportions. A student-t test was used to compare the averages. The p-value was fixed to 0.05. The study was conducted in accordance with the National Ethics Committee (ESP/CE/030/13).
Results
During the study period, 984 patients visited one of the Rheumatology units for rheumatic complaints. The diagnosis of SpA was made in 105 patients (10.7%). 78 Patients fulfilled the Amor or ESSG criteria and 27 patients were diagnosed according to clinical grounds only based on the rheumatologist experience. The frequencies for the retrospective subtypes were 5.0% for nr-axSpA, 4.3% for ReA, 1.0% for AS. One patient was seen with PsA, SAPHO syndrome or IBD associated arthritis. Sixty-two patients (59%) were male with a male/female sex ratio of 1.4. The mean age of the patients was 44.7±13.5 years; their median disease duration was 3.6 years (range: 0.3 -15 years).
Their average age at the onset of symptom was 41.3±12.4 years. Table 1 reports the different types of SpA encountered. Inflammatory back pain (86.2%) and buttock pain (72.4%) were the most frequent symptoms seen in axSpA while asymmetrical oligoarthritis (80.8%) and plantar talalgias (66.0%) as the most frequently encountered features in pSpA. Table 2 shows the demographic, clinical data and clinical assessment scores of patients with axSpA. Fifty-nine patients (56.2%)
presented with axSpA and all of them had standard radiographs of sacroiliac joints. Ten patients (6 males and 4 females) showed radiographic sacroiliitis as defined by modified New York criteria and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Discussion
The prevalence of SpA was 10.7% among rheumatic patients during the 6-month period of the current study and is higher than that found by Malemba and al. (7.5%) based on an extensive review of patients medical records seen by rheumatologists at the UHK. In this hospital-based study, diagnostic criteria applied by rheumatologists were used to improve their clinical diagnosis while just application of the criteria of Amor and ESSG in medical records might lead to misdiagnosis.
Moreover, in our environment HLA typing is not feasible and because of the low frequency of HLA B27 also not very well performing. We would state that ESSG and Amor criteria would also need specific validation studies in our region. The issue of HLA B27 mentioned above and the lack of availability of MRI in our regions as well the economic constraints, make the application of the ASAS criteria that heavily rely on this items not feasible as is probably also the case in many other parts of the world. We observed 105 cases of SpA and a male/female sex ratio of 1.4. More men were (18) (19) (20) (21) (22) . The mean age and the age at the onset of symptom were higher than in the series reported in the western countries, but in agreement with the literature reported from the subSaharan region (4, (18) (19) (20) (21) (22) . A completely different environment (differences in sanitary equipments, differences in infections occurring in these populations) on top of a different genetic background might be responsible for a different disease presentation and perhaps as a consequence also later diagnosis ( features probably because of a protective role played by the local genetic factors (7, 8) . Further genetic research could be interesting in this field. In this study we observed 10 cases of AS (1.0%).
This scarcity seems to be related to the low frequency of HLA B27 gene in this population (23) . Less male predominance has been observed among Congolese patients with SpA, AS and nr-axSpA compared to Caucasians (3). However different demographical and methodological characteristics could also contribute to the explanations of gender differences observed. The proportion of females could be underestimated because most patients with pelvic inflammatory disease would be seen in Gynecology departments in our country where full rheumatologic evaluations and sacroiliac radiographs are not systematically performed. Patients with AS had a mean age of 48.2 years (SD 4.7)
with the age of onset typically older as reported in other sub-Saharan literature and with no family history of SpA and also a relative rarity of extra-articular features, notably uveitis also in accordance with data of the literature of SpA in sub-Saharan Africa (4, 6, (20) (21) (22) .
Pertinent differences between AS and nr-axSpA (83.1% of axSpA) in this study included significantly longer disease duration and mean age at consultation for AS (p<0.05). Apart from the fact of AS developing after an initial period of disease with negative radiographical findings, this longer disease duration before consultation can also be explained by the many problems concerning organization of health care, the poverty of the Congolese population having no access to treatment, as well as by cultural specificities with difficulties in understanding the concept of chronicity of a disease (24). No significant difference was observed regarding extra articular features, parameters of disease activity and function as well as inflammatory markers including BASDAI, BASFI, ESR and CRP between these two groups. This is of course difficult to judge in a cross-sectional study of different disease entities when AS might be just the "natural evolution" of nr-axSpA (25-27). Only one case of PsA was 
Conclusion
SpA is not rare in outpatients attending Rheumatology units in DR Congo. A population-based study would improve the understanding of this disease spectrum in central Africa. Such a study will need to take into account the differential infectious background, problems related to the health care system and poverty of the population and differential genetics in this environment. Classification criteria validated in the western world will not necessarily perform the same in our region. Also measurements as BASDAI and BASFI should be critically evaluated and compared to specific norm data. Funding: This research did not received any specific grant from any funding agency from the public, commercial or not-for-profit sectors
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